Stock LABP LANDOS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Landos Biopharma, Inc.

Equities

LABP

US5150692011

Delayed Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
22.93 USD +0.58% Intraday chart for Landos Biopharma, Inc. -.--% +526.50%
Jun. 13 AbbVie inks immune disorder drug licensing deal with China's FutureGen RE
May. 24 Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
AbbVie inks immune disorder drug licensing deal with China's FutureGen
RE
Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index
CI
AbbVie Completes Acquisition of Landos Biopharma
MT
Landos Biopharma, Inc. Announces Board and Executive Changes
CI
AbbVie Completes Acquisition of Landos Biopharma
PR
Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from NASDAQ Composite Index
CI
AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders.
CI
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
BU
Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
PR
North American Morning Briefing : Stocks Seen -2-
DJ
HC Wainwright Downgrades Landos Biopharma to Neutral From Buy
MT
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
BU
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP
PR
Deals of the day-Mergers and acquisitions
RE
Sector Update: Health Care Stocks Decline Late Afternoon
MT
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE
PR
Top Midday Gainers
MT
Sector Update: Health Care Stocks Softer in Afternoon Trading
MT
Shareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LABP Stock
  4. News Landos Biopharma, Inc.